Long-Jyun Su

About

Dr. Su serves as the CEO and Chairman of LuminX Biotech and MediDiamond Inc. He earned his PhD degree in Chemistry from NTU and pursued postdoctoral studies at Academia Sinica. His focus lies in the realm of nanomaterial and bio-application development. In 2020, he founded LuminX Biotech, introducing the LuminX Cell Tracking Enabling Platform (LCTEP) dedicated to pre-clinical and clinical assessment of cell therapies. This platform exhibits the capability to ensure the precise homing of therapeutic cells to targeted organs, ascertain acute and long-term viability, assess desired functionalities, and detect any unintended accumulations, thereby significantly enhancing the safety, efficacy, and potency of cellular drugs before progressing to human trials.

Dr. Su's role as a Co-founder of BioDiamond biotechnology Co., Ltd. showcases his entrepreneurial aptitude, with profits surpassing initial investments, marking a successful exit strategy. His experience as a serial entrepreneur emphasizes his capacity to translate academic research into practical industrial applications. While leading BioDiamond during his Ph.D., he achieved a remarkable 50% profit increase over invested capital, demonstrating his strategic prowess. He is the inventor of the LuminX Cell Tracking Enabling Platform, addressing needs in cell therapy, exosome therpay, regenerative medicine, cancer research, tumor metastasis, and immunotherapy. Dr. Su envisions advancing the global bio-industry through his approach of "applying what I've learned into practice," a philosophy that drives his accomplishments.

Employment

• MediDiamond Inc CEO
  2020 - Present
• LuminX Biotech Co., Ltd CEO
  2020 - Present
• Institute of Atomic and Molecular Sciences, Academia Sinica Postdoctoral Fellow
  2018 - 2019
• BioDiamond Co., Ltd CTO
  2015 - 2019

Education

• National Taiwan University Ph.D
  2013 - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Evaluation of Nanodiamond-in-Oil Emulsion with Snake Venom to Enhance Potent Antibody Induction in Mice and Rabbits
  Nanomaterials 2025 DOI: 10.3390/nano15191518
  +Save
• Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications
  Journal of Biomedical Science 2021 DOI: 10.1186/s12929-021-00725-7
  +Save
• Fluorescent Nanodiamonds Enable Long-Term Detection of Human Adipose-Derived Stem/Stromal Cells in an In Vivo Chondrogenesis Model Using Decellularized Extracellular Matrices and Fibrin Glue Polymer
  Polymers 2019 DOI: 10.3390/polym11091391
  +Save
• Intracellular Delivery of Luciferase with Fluorescent Nanodiamonds for Dual-Modality Imaging of Human Stem Cells
  Bioconjugate Chemistry 2019 DOI: 10.1021/acs.bioconjchem.9b00458
  +Save
• Fluorescent nanodiamonds enable quantitative tracking of human mesenchymal stem cells in miniature pigs
  Scientific Reports 2017 DOI: 10.1038/srep45607
  +Save
• Wide-field imaging and flow cytometric analysis of cancer cells in blood by fluorescent nanodiamond labeling and time gating
  Scientific Reports 2014 DOI: 10.1038/srep05574
  +Save
• Highly Fluorescent Nanodiamonds Protein‐Functionalized for Cell Labeling and Targeting
  Advanced Functional Materials 2013 DOI: 10.1002/adfm.201301075
  +Save
• Creation of high density ensembles of nitrogen-vacancy centers in nitrogen-rich type Ib nanodiamonds
  Nanotechnology 2013 DOI: 10.1088/0957-4484/24/31/315702
  +Save
• Photoacoustic contrast imaging of biological tissues with nanodiamonds fabricated for high near-infrared absorbance
  Journal of Biomedical Optics 2013 DOI: 10.1117/1.jbo.18.2.026018
  +Save
• Tip-enhanced sub-diffraction fluorescence imaging of nitrogen-vacancy centers in nanodiamonds
  Applied Physics Letters 2013 DOI: 10.1063/1.4773364
  +Save